Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity

Cisplatin, one of the most active anticancer agents, is widely used in standard chemotherapy for various cancers. Cisplatin is more poorly tolerated than other chemotherapeutic drugs, and the main dose-limiting toxicity of cisplatin is its nephrotoxicity, which is dose-dependent. Although less toxic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Arita, Masashi, Watanabe, Satoshi, Aoki, Nobumasa, Kuwahara, Shoji, Suzuki, Ryo, Goto, Sawako, Abe, Yuko, Takahashi, Miho, Sato, Miyuki, Hokari, Satoshi, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Hayashi, Masachika, Ohshima, Yasuyoshi, Kabasawa, Hideyuki, Hosojima, Michihiro, Koya, Toshiyuki, Saito, Akihiko, Kikuchi, Toshiaki
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7804437/
https://ncbi.nlm.nih.gov/pubmed/33437029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-80853-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы